Sign in
4

Changes in Ownership

KYNTRA BIO, INC. Filed Acc 0001209191-20-062619

SVP, Clinical Dev, Drug Safety gave up 2,728 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Kouchakji Elias · SVP, Clinical Dev, Drug Safety

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-12-07 Shares withheld for taxes : show line 1 in the form −2,728 $41.99 $114,549 131,767 D
Loading xslF345X03/doc4.xml…